NASDAQ:CDT CDT Equity (CDT) Stock Price, News & Analysis $0.90 -0.09 (-8.69%) As of 03:42 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About CDT Equity Stock (NASDAQ:CDT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CDT Equity alerts:Sign Up Key Stats Today's Range$0.85▼$0.9750-Day Range$0.99▼$89.7552-Week Range$0.85▼$44,450.00Volume308,731 shsAverage Volume63,694 shsMarket Capitalization$27.12 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview CDT Equity, Inc., traded on the Nasdaq under the symbol CDT, is associated with Conduit Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious autoimmune and inflammatory diseases. The company’s business model centers on acquiring and advancing clinical-stage drug candidates through partnerships with academic institutions and pharmaceutical companies. Its portfolio has included investigational therapies intended to address conditions such as systemic sclerosis and other immune-mediated diseases, although the status and composition of its development programs may change as clinical and corporate activities progress. Conduit Pharmaceuticals was established to help translate externally developed drug candidates into commercial medicines. Publicly available information about CDT Equity’s current operating structure, leadership, and geographic activities is limited.AI Generated. May Contain Errors. Read More CDT Equity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks1st Percentile Overall ScoreCDT MarketRank™: CDT Equity scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingCDT Equity has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCDT Equity has only been the subject of 1 research reports in the past 90 days.Read more about CDT Equity's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of CDT Equity is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CDT Equity is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted32.91% of the float of CDT Equity has been sold short.Short Interest Ratio / Days to CoverCDT Equity has a short interest ratio ("days to cover") of 0.03, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CDT Equity has recently increased by 467.91%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCDT Equity does not currently pay a dividend.Dividend GrowthCDT Equity does not have a long track record of dividend growth. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 4 news articles for CDT Equity this week, compared to 3 articles on an average week. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, CDT Equity insiders have not sold or bought any company stock.Percentage Held by Insiders7.34% of the stock of CDT Equity is held by insiders.Percentage Held by Institutions3.29% of the stock of CDT Equity is held by institutions.Read more about CDT Equity's insider trading history. Receive CDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CDT Equity and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CDT Stock News HeadlinesCDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug DiscoverySeptember 29, 2026 | finance.yahoo.comCDT Equity Inc.: CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug DiscoverySeptember 29, 2026 | finanznachrichten.deMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.October 5 at 1:00 AM | Paradigm Press (Ad)CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug DiscoverySeptember 29, 2026 | globenewswire.comCDT Equity Board Approves 1-For-25 Reverse Stock Split, Pre-market Shares DownSeptember 26, 2026 | rttnews.comCDT Announces 1-for-25 Reverse Stock Split To Meet Nasdaq Compliance; Pre-market Stock PlungesSeptember 26, 2026 | rttnews.comCDT Equity Announces Reverse Stock Split to Maintain ListingSeptember 25, 2026 | tipranks.comCDT Equity Inc. Announces Reverse Stock SplitSeptember 25, 2026 | globenewswire.comSee More Headlines CDT Stock Analysis - Frequently Asked Questions How have CDT shares performed this year? CDT Equity's stock was trading at $8,000.00 at the start of the year. Since then, CDT stock has decreased by 100.0% and is now trading at $0.9020. How were CDT Equity's earnings last quarter? CDT Equity Inc. (NASDAQ:CDT) posted its quarterly earnings data on Wednesday, August, 12th. The company reported ($217.75) earnings per share for the quarter. When did CDT Equity's stock split? Shares of CDT Equity reverse split before market open on Friday, March 27th 2026.The 1-25 reverse split was announced on Wednesday, March 25th 2026. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 26th 2026. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of CDT Equity? Shares of CDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CDT Equity own? Based on aggregate information from My MarketBeat watchlists, some other companies that CDT Equity investors own include BIOLASE (BIOL), Dare Bioscience (DARE), AMC Entertainment (AMC), Canoo (GOEV) and Jiuzi (JZXN). Company Calendar Last Earnings8/12/2026Today10/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (28m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 CDT's financial health is in the Red zone, according to TradeSmith. CDT has been in this zone for over 28 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CDT Previous SymbolNASDAQ:CDT CIK1896212 Webwww.cdtequity.com Phone(646) 491-9132FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)($3,354.31) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$39.22 million Net MarginsN/A Pretax MarginN/A Return on Equity-72.25% Return on Assets-55.44% Debt Debt-to-Equity RatioN/A Current Ratio0.13 Quick Ratio0.13 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares30,000Free Float29,000Market Cap$27.39 thousand OptionableNot Optionable Beta1.59 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:CDT) was last updated on 10/5/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CDT Equity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CDT Equity With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
